ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,010Medicare Part D Prescriptions Filled, Including Refills

Rank: 182 out of 2035

$792K Total Retail Price of All Prescriptions

Rank: 98 out of 2035

784 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
7% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 784 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

10% of this provider’s 784 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

1% of this provider’s 8,974 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$79 was the average price of a prescription from this provider, compared to $63 among peers.

Prescriptions per Patient

13 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
SIMVASTATIN 378 339 1 1
LISINOPRIL 346 320 2 3
LEVOTHYROXINE SODIUM 301 269 3 4
OMEPRAZOLE 294 273 4 5
LOVASTATIN 268 252 5 33
HYDROCODONE-ACETAMINOPHEN 267 201 S3 6 2
ZOLPIDEM TARTRATE 257 210 7 21
ATENOLOL 235 216 8 10
AMLODIPINE BESYLATE 234 219 9 6
METFORMIN HCL 204 179 10 9
LISINOPRIL-HYDROCHLOROTHIAZIDE 203 180 11 26
HYDROCHLOROTHIAZIDE 181 158 12 12
ATORVASTATIN CALCIUM 165 139 13 13
GLIMEPIRIDE 163 156 14 55
FUROSEMIDE 141 127 15 7
PRAVASTATIN SODIUM 139 137 16 17
LOSARTAN POTASSIUM 139 128 16 15
POTASSIUM CHLORIDE 130 127 18 18
ALLOPURINOL 129 118 19 34
AZITHROMYCIN 128 119 20 39
CITALOPRAM HBR 110 101 21 20
FLUTICASONE PROPIONATE 105 97 22 29
MELOXICAM 104 99 23 56
GABAPENTIN 102 98 24 14
ALPRAZOLAM 98 92 25 109
TRIAMTERENE-HCTZ 96 95 26 35
TAMSULOSIN HCL 88 86 27 25
WARFARIN SODIUM 86 80 28 11
PREDNISONE 85 80 29 36
METOPROLOL SUCCINATE 80 71 30 16
ALENDRONATE SODIUM 79 73 31 27
CLOPIDOGREL 77 70 32 30
METOPROLOL TARTRATE 74 67 33 8
PANTOPRAZOLE SODIUM 69 69 34 42
DIOVAN 69 69 34 76
CRESTOR 69 67 34 41
TRAMADOL HCL 68 64 37 19
CIPROFLOXACIN HCL 67 58 38 63
PROAIR HFA 66 56 39 31
METFORMIN HCL ER 64 64 40 78
LANTUS SOLOSTAR 61 32 41 66
LOSARTAN-HYDROCHLOROTHIAZIDE 55 48 42 47
ADVAIR DISKUS 55 50 42 38
ZETIA 54 54 44 84
DIOVAN HCT 52 52 45 126
ESCITALOPRAM OXALATE 51 43 46 77
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.